
News
Advertisement


Advertisement




Advertisement



Protecting Subjects: The IRBs Next Steps

SITES : Incorporating Standard of Care in Study Budgets Benefits of CTMS at the Investigative Site Also in this issue : FDA Transparency Efforts to Impact Research, Survey Assesses Europe?s Clinical Trials Directive, Tapping into the Potential of Pharmacists, Biosimilars Make Headway in the U.S.

Act cover

Do Sites Prefer a Sponsor Company or CRO to Run Their Clinical Trial?

Industry news focusing on the people and organizations who work in the clinical trials profession.
















Advertisement
Advertisement